This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hellal-Levy, C. Articles by Rafestin-Oblin, M.-E. Search for Related Content PubMed PubMed Citation Articles by Hellal-Levy, C. Articles by Rafestin-Oblin, M.-E.

Crucial Role of the H11-H12 Loop in Stabilizing the Active Conformation of the Human Mineralocorticoid Receptor

INSERM U478 (C.H.-L., A.S., M.-E.R.-O.) Faculté de médecine Xavier Bichat Institut fédératif de recherche 02 B.P. 416, 75780 Paris Cédex 18, France
Institut de Génétique et de Biologie Moléculaire et Cellulaire (J.F., J.-M.W., D.M.) B.P. 163, 67404 Illkirch Cédex CU de Strasbourg, France

The crystal structures of ligand-free and agonist-associated ligand-binding domain (LBD) of nuclear receptors (NRs) reveal that the amphipathic helix H12 is folded back toward the LBD core in the agonist-associated conformation, allowing the binding of coactivators. We used alanine scanning mutagenesis to explore the role of the residues of the loop connecting H11 and H12 in the activation of the human mineralocorticoid receptor (hMR), a member of the NRs family. H950A retained the ligand binding and transcriptional activities of the wild-type receptor and interacted with coactivators. In contrast F956A had no receptor functions. Aldosterone bound to the mutant hMRs (L952A, K953A, V954A, E955A, P957A) with nearly the same affinity as to the wild- type receptor and caused a receptor conformational change in these mutant hMRs as it does for the wild-type receptor. But the aldosterone-induced transcriptional activity of the mutant hMRs was lower (L952A, E955A, P957A) than that of the wild-type receptor or completely abolished (K953A, V954A) and their interaction with coactivators was impaired (E955A) or suppressed (L952A, K953A, V954A, P957A). In the light of a hMR-LBD model based on the structure of the progesterone-associated receptor-LBD, we propose that the integrity of the H11-H12 loop is crucial for folding the receptor into a ligand-binding competent state and for establishing the network of contacts that stabilize the active receptor conformation.

This article has been cited by other articles:

				L. R. Stow, M. L. Gumz, I. J. Lynch, M. M. Greenlee, A. Rudin, B. D. Cain, and C. S. Wingo Aldosterone Modulates Steroid Receptor Binding to the Endothelin-1 Gene (edn1) J. Biol. Chem., October 30, 2009; 284(44): 30087 - 30096. [Abstract] [Full Text] [PDF]

				J. B. Pippal, Y. Yao, F. M. Rogerson, and P. J. Fuller Structural and Functional Characterization of the Interdomain Interaction in the Mineralocorticoid Receptor Mol. Endocrinol., September 1, 2009; 23(9): 1360 - 1370. [Abstract] [Full Text] [PDF]

				J. Yang and M. J Young The mineralocorticoid receptor and its coregulators J. Mol. Endocrinol., August 1, 2009; 43(2): 53 - 64. [Abstract] [Full Text] [PDF]

				I. Petit-Topin, N. Turque, J. Fagart, M. Fay, A. Ulmann, E. Gainer, and M.-E. Rafestin-Oblin Met909 Plays a Key Role in the Activation of the Progesterone Receptor and Also in the High Potency of 13-Ethyl Progestins Mol. Pharmacol., June 1, 2009; 75(6): 1317 - 1324. [Abstract] [Full Text] [PDF]

				J. B Pippal and P. J Fuller Structure-function relationships in the mineralocorticoid receptor J. Mol. Endocrinol., December 1, 2008; 41(6): 405 - 413. [Abstract] [Full Text] [PDF]

				G. Pochetti, C. Godio, N. Mitro, D. Caruso, A. Galmozzi, S. Scurati, F. Loiodice, G. Fracchiolla, P. Tortorella, A. Laghezza, et al. Insights into the Mechanism of Partial Agonism: CRYSTAL STRUCTURES OF THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR {gamma} LIGAND-BINDING DOMAIN IN THE COMPLEX WITH TWO ENANTIOMERIC LIGANDS J. Biol. Chem., June 8, 2007; 282(23): 17314 - 17324. [Abstract] [Full Text] [PDF]

				A.-N. Takeda, G. M. Pinon, M. Bens, J. Fagart, M.-E. Rafestin-Oblin, and A. Vandewalle The Synthetic Androgen Methyltrienolone (R1881) Acts as a Potent Antagonist of the Mineralocorticoid Receptor Mol. Pharmacol., February 1, 2007; 71(2): 473 - 482. [Abstract] [Full Text] [PDF]

				F. G. Riepe, J. Finkeldei, L. de Sanctis, S. Einaudi, A. Testa, B. Karges, M. Peter, M. Viemann, J. Grotzinger, W. G. Sippell, et al. Elucidating the Underlying Molecular Pathogenesis of NR3C2 Mutants Causing Autosomal Dominant Pseudohypoaldosteronism Type 1 J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4552 - 4561. [Abstract] [Full Text] [PDF]

				F. L. Fernandes-Rosa, M. de Castro, A. C. Latronico, W. G. Sippell, F. G. Riepe, and S. R. Antonini Recurrence of the R947X Mutation in Unrelated Families with Autosomal Dominant Pseudohypoaldosteronism Type 1: Evidence for a Mutational Hot Spot in the Mineralocorticoid Receptor Gene J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3671 - 3675. [Abstract] [Full Text] [PDF]

				Y. A. Elhaji, I. Stoica, S. Dennis, E. O. Purisima, and M. A. Trifiro Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity Hum. Mol. Genet., March 15, 2006; 15(6): 921 - 931. [Abstract] [Full Text] [PDF]

				R. K. Bledsoe, K. P. Madauss, J. A. Holt, C. J. Apolito, M. H. Lambert, K. H. Pearce, T. B. Stanley, E. L. Stewart, R. P. Trump, T. M. Willson, et al. A Ligand-mediated Hydrogen Bond Network Required for the Activation of the Mineralocorticoid Receptor J. Biol. Chem., September 2, 2005; 280(35): 31283 - 31293. [Abstract] [Full Text] [PDF]

				L. Pascual-Le Tallec and M. Lombes The Mineralocorticoid Receptor: A Journey Exploring Its Diversity and Specificity of Action Mol. Endocrinol., September 1, 2005; 19(9): 2211 - 2221. [Abstract] [Full Text] [PDF]

				L. Pascual-Le Tallec, F. Simone, S. Viengchareun, G. Meduri, M. J. Thirman, and M. Lombes The Elongation Factor ELL (Eleven-Nineteen Lysine-Rich Leukemia) Is a Selective Coregulator for Steroid Receptor Functions Mol. Endocrinol., May 1, 2005; 19(5): 1158 - 1169. [Abstract] [Full Text] [PDF]

				J. Fagart, C. Seguin, G. M. Pinon, and M.-E. Rafestin-Oblin The Met852 Residue Is a Key Organizer of the Ligand-Binding Cavity of the Human Mineralocorticoid Receptor Mol. Pharmacol., May 1, 2005; 67(5): 1714 - 1722. [Abstract] [Full Text] [PDF]

				P. Sartorato, F. Cluzeaud, J. Fagart, S. Viengchareun, M. Lombes, and M.-C. Zennaro New Naturally Occurring Missense Mutations of the Human Mineralocorticoid Receptor Disclose Important Residues Involved in Dynamic Interactions with Deoxyribonucleic Acid, Intracellular Trafficking, and Ligand Binding Mol. Endocrinol., September 1, 2004; 18(9): 2151 - 2165. [Abstract] [Full Text] [PDF]

				L. Pascual-Le Tallec, O. Kirsh, M.-C. Lecomte, S. Viengchareun, M.-C. Zennaro, A. Dejean, and M. Lombes Protein Inhibitor of Activated Signal Transducer and Activator of Transcription 1 Interacts with the N-Terminal Domain of Mineralocorticoid Receptor and Represses Its Transcriptional Activity: Implication of Small Ubiquitin-Related Modifier 1 Modification Mol. Endocrinol., December 1, 2003; 17(12): 2529 - 2542. [Abstract] [Full Text] [PDF]

				S. Benko, J. D. Love, M. Beladi, J. W. R. Schwabe, and L. Nagy Molecular Determinants of the Balance between Co-repressor and Co-activator Recruitment to the Retinoic Acid Receptor J. Biol. Chem., October 31, 2003; 278(44): 43797 - 43806. [Abstract] [Full Text] [PDF]

				M.-E. Rafestin-Oblin, J. Fagart, A. Souque, C. Seguin, M. Bens, and A. Vandewalle 11beta -Hydroxyprogesterone Acts as a Mineralocorticoid Agonist in Stimulating Na+ Absorption in Mammalian Principal Cortical Collecting Duct Cells Mol. Pharmacol., December 1, 2002; 62(6): 1306 - 1313. [Abstract] [Full Text] [PDF]

				M.-C. Zennaro, A. Souque, S. Viengchareun, E. Poisson, and M. Lombes A New Human MR Splice Variant Is a Ligand-Independent Transactivator Modulating Corticosteroid Action Mol. Endocrinol., September 1, 2001; 15(9): 1586 - 1598. [Abstract] [Full Text] [PDF]

				G. Auzou, J. Fagart, A. Souque, C. Hellal-Lévy, J.-M. Wurtz, D. Moras, and M.-E. Rafestin-Oblin A Single Amino Acid Mutation of Ala-773 in the Mineralocorticoid Receptor Confers Agonist Properties to 11beta -Substituted Spirolactones Mol. Pharmacol., October 1, 2000; 58(4): 684 - 691. [Abstract] [Full Text]